NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/30/2023
Back to search
Official data from USPTO
ZUSTELVI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
05/30/2023
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
05/11/2021
Registration date
05/30/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/30/2023
Last transaction
05/30/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
CHUO, EMILY M
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NOVARTIS AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/30/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/12/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/12/2023
GPNX
NOTIFICATION PROCESSED BY IB
03/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2023
PUBO
PUBLISHED FOR OPPOSITION
03/14/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/22/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/22/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2023
ATRV
ATTORNEY REVIEW COMPLETED
02/09/2023
FINA
FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
02/06/2023
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
02/06/2023
CRTP
REG. CANCELLED - RESTORED TO PENDENCY
05/13/2022
APET
ASSIGNED TO PETITION STAFF
05/11/2022
RCII
REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED
05/06/2022
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
02/10/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
01/31/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
11/14/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/26/2021
PUBO
PUBLISHED FOR OPPOSITION
10/26/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/06/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2021
DOCK
ASSIGNED TO EXAMINER
09/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/13/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/09/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/09/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/09/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/09/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/07/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/06/2021
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
06/25/2021
Continuous trademark protection
Get notified about every new filing that threatens ZUSTELVI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.